Stelara 45 MG/0.5 ML syringe 0.5ML

Ended Awarded

Contract number
SPE2DB25FD18E
Awardee
Awarding agency
Obligated
$91,715

Award facts

Contract value 100% obligated
$91,715.06 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Stelara 45 mg/0.5 mL syringes valued at $91,715.06, with completion targeted for September 30, 2025. This is a firm fixed-price delivery order issued without a set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide.

AmerisourceBergen Drug Corp serves as a critical pharmaceutical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive portfolio of federal contract awards demonstrates its capability to meet defense healthcare requirements through open competition. The DLA Troop Support Medical contract vehicle represents a strategic approach to pharmaceutical procurement, with plans underway for future Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards and contractors to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.

Quick answers

Who was awarded contract SPE2DB25FD18E?

SPE2DB25FD18E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.

How much is contract SPE2DB25FD18E worth?

The government has obligated $91,715 on SPE2DB25FD18E.

Is contract SPE2DB25FD18E an order under another contract?

Yes. SPE2DB25FD18E is a delivery order under SPE2DB20D2014, an indefinite delivery contract.

Was contract SPE2DB25FD18E competed?

The extent of competition for SPE2DB25FD18E was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award